Fig. 6From: Circadian rhythm-associated lncRNA RP11-414H17.5 as a key therapeutic target in osteosarcoma affects the tumor immune microenvironment and enhances malignancyPerforming PCA and DECRLs box plot analysis in all cohorts. The box plots showed that the expression of RP11-414H17.5 (A), RP11-750H9.5 (B), and RP11-136I14.5 (C) were significantly different between different risk subgroups. PCA results indicated that these 3-risk DECRLs could significantly distinguish between the different risk subgroups (D), whereas the 51 candidate DECRLs (E) and all the genes (F) were less effectiveBack to article page